Combination of ECMO and CytoSorb hemoadsorption in COVID-19 patients and beyond
- About CytoSorb, COVID-19, ECMO
Combination of ECMO and CytoSorb hemoadsorption in COVID-19 patients and beyond
Chair: Roberto Lorusso, Maastricht/The Netherlands
Speakers: L. Christian Napp, Hannover/Germany; Alexander Supady, Freiburg/Germany; Nader Moazami, New York/USA; Ali Akil, Ibbenbueren/Germany
Agenda
Rationale for the use of CytoSorb in ECMO patients
L. Christian Napp, Hannover/Germany
Cytokine adsorption in severe COVID-19 pneumonia requiring ECMO – the CYCOV study
Alexander Supady, Freiburg/Germany
First clinical experiences in the USA
Nader Moazami, New York/USA
Reduction of hyperinflammation, septic shock and MOF – we can do it better
Ali Akil, Ibbenbueren/Germany
Share
|
Combination of ECMO and CytoSorb hemoadsorption in COVID-19 patients and beyond
- July 7, 2020
- About CytoSorb, COVID-19, ECMO
Share
|
Combination of ECMO and CytoSorb hemoadsorption in COVID-19 patients and beyond
Chair: Roberto Lorusso, Maastricht/The Netherlands
Speakers: L. Christian Napp, Hannover/Germany; Alexander Supady, Freiburg/Germany; Nader Moazami, New York/USA; Ali Akil, Ibbenbueren/Germany
Agenda
Rationale for the use of CytoSorb in ECMO patients
L. Christian Napp, Hannover/Germany
Cytokine adsorption in severe COVID-19 pneumonia requiring ECMO – the CYCOV study
Alexander Supady, Freiburg/Germany
First clinical experiences in the USA
Nader Moazami, New York/USA
Reduction of hyperinflammation, septic shock and MOF – we can do it better
Ali Akil, Ibbenbueren/Germany
More Videos



